Indian companies that list overseas will have to later launch on a domestic bourse under policy changes being considered by government officials, sources told Reuters, a move that global investors fear will harm valuations.
(RTTNews) - The Malaysia stock market on Friday halted the two-day slide in which it had tumbled almost 30 points or 2 percent. The Kuala Lumpur Composite Index now rests just above the 1,500-point plateau and it may tick slightly higher again on Monday.
Australian investment bank Macquarie Group said on Monday it expects first-half earnings to be about 35% lower, citing challenging market conditions due to the coronavirus and uncertainties about the global economic recovery.
Australia's Home Affairs Minister Peter Dutton on Sunday defended the government's right to intelligence raids to prevent foreign interference, after China condemned searches on the homes of its journalists working in Australia.
(RTTNews) - The South Korea stock market has finished higher in two straight sessions, gathering more than 20 points or 0.9 percent along the way. The KOSPI now rests just beneath the 2,400-point plateau and it figures to remain in that neighborhood again on Monday.
Japan's manufacturers remained pessimistic for the 14th straight month in September, and though the gloom eased somewhat the broad results of the Reuters Tankan survey pointed to a painfully slow recovery for the coronavirus-stricken economy.
China's National Food and Strategic Reserves Administration has asked the country's major cobalt producers to submit proposals to sell their metal to the state, sources with direct knowledge of the matter told Reuters.
You would think a deadly pandemic might put a damper on big-ticket purchases like car sales. And you'd be right. But not if you're talking about used cars -- and especially not if you're talking about online sales of used cars.
Since cloud database platform provider MongoDB (NASDAQ: MDB) released its fiscal second-quarter 2021 earnings report on Sept. 2, its shares have experienced an extended swoon, falling 17% to date despite vigorous results. The reasons aren't hard to identify. Some investors chos
Most people are well aware that their wages are taxed. But there are some other income sources you may be much more surprised to find Uncle Sam taking a cut of. Here are three of them.
There's a certain allure of finding the next big thing, getting in on the ground floor, and riding it to untold riches. And there are certainly those investors who feel that the best way to make this dream a reality is by putting their hard-earned cash to work in the next red-ho
Unai Emery had a disappointing return to Spanish soccer as his Villarreal side could only draw 1-1 at home to promoted Huesca in an eventful La Liga game which had three goals ruled out and a serious-looking injury to Villarreal's Francis Coquelin.
Six-times world champion Lewis Hamilton took his tally of Formula One wins to 90 and the brink of Michael Schumacher's record on Sunday, but he said it felt like he had just done three in a day.
National Football League players staged pre-game protests taking a knee during the playing of the U.S. national anthem on Sunday in mostly empty stadiums, avoiding the embarrassment of fans booing that overshadowed the season opener.
Everton justified the pre-season optimism as Dominic Calvert-Lewin's header earned them an impressive 1-0 win at Tottenham Hotspur in their Premier League opener on Sunday -- the Merseyside club's first win over Spurs since 2012.
Biotech stocks have proven time and again to be outstanding growth vehicles for risk-tolerant investors. Underscoring this point, companies like Axsome Therapeutics, Immunomedics, and Novavax have each generated enormous returns on capital for investors within an exceedingly sho
By its own admission, one of the most significant limiting factors for Peloton's (NASDAQ: PTON) growth is the high price of its products. "We've long believed that our price points have represented one of the biggest barriers to the purchase of our products," CFO Jill Woodworth
Within the next week, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) expect to reach their goal of enrolling 30,000 participants in the phase 2/3 clinical trial testing their coronavirus vaccine, BNT162b2.
Checked
19 minutes 11 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article